Consilium MedicumConsilium MedicumConsilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum69017910.26442/20751753.2025.8.203064ArticlesСтатьиReview ArticleCardiovascular diseases in the long-term after surviving malignant neoplasms: A reviewСердечно-сосудистые заболевания в отдаленные сроки после перенесенного злокачественного новообразования: обзорhttps://orcid.org/0000-0003-4463-2897PoltavskayaMaria G.ПолтавскаяМария Георгиевна
Russian Federation

D. Sci. (Med.)

доктор медицинских наук, профессор кафедры кардиологии, функциональной и ультразвуковой диагностики

poltavskaya_m_g@staff.sechenov.ruhttps://orcid.org/0000-0003-2972-1795NovikovaAlena I.НовиковаАлена Игоревна
Russian Federation

Assistant

ассистент кафедры кардиологии, функциональной и ультразвуковой диагностики

poltavskaya_m_g@staff.sechenov.ruhttps://orcid.org/0009-0005-9593-5339BezlyudskiyArtem L.БезлюдскийАртем Леонидович
Russian Federation

Student

студент

poltavskaya_m_g@staff.sechenov.ruSechenov First Moscow State Medical University (Sechenov University)ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)07092025278Outpatient issuesПоликлинические вопросы4384450709202507092025Copyright ©; 2025, Consilium MedicumCopyright ©; 2025, ООО "Консилиум Медикум"2025Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://consilium.orscience.ru/2075-1753/article/view/690179

The article provides an overview of the literature data on cardiovascular diseases in cancer survivors over the long term. Particular attention is paid to the adverse effects of radiation therapy. Clinical guidelines for cardiac risk stratification and monitoring of long-term cardiovascular complications of antitumor treatment are provided. A clinical case of a radiation-associated heart disease is presented.

Представлен обзор литературных данных, посвященных сердечно-сосудистой патологии у пациентов в отдаленные сроки после перенесенного злокачественного новообразования. Особое внимание уделено неблагоприятным последствиям лучевой терапии. Приведены клинические рекомендации по стратификации кардиального риска и мониторингу отдаленных сердечно-сосудистых осложнений противоопухолевой терапии. Описано клиническое наблюдение лучевой патологии сердца.

cancer survivorscardiotoxicityradiation-associated heart diseasesлица, перенесшие злокачественное новообразованиекардиотоксичностьрадиационно-ассоциированные заболевания сердцаZoller B, Ji J, Sundquist J, Sundquist K. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48(12):1875-83.Zoller B, Ji J, Sundquist J, Sundquist K. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48(1):121-8.Strongman H, Gadd S, Matthews A, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet. 2019;394(10203):1041-54.Paterson DI, Wiebe N, Cheung WY, et al. Incident Cardiovascular Disease Among Adults With Cancer: A Population-Based Cohort Study. JACC CardioOncol. 2022;4(1):85-94.Zhang F, Wang K, Du P, et al. Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies. Neurology. 2021;96(4):e513-26.Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44.Dardiotis E, Aloizou AM, Markoula S, et al. Cancer-associated stroke: pathophysiology, detection and management (Review). Int J Oncol. 2019;54(3):779-96.Muhandiramge J, John R Zalcberg JR, van Londen GJ. Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology. Curr Oncol Rep. 2022;24:1579-92.Stoltzfus KC, Zhang Y, Sturgeon K, et al. Fatal heart disease among cancer patients. Nat Commun. 2020;11(1):2011.Okwuosa TM, Morgans A, Rhee JW, et al. Impact of hormonal therapies for treatment of hormone dependent cancers (breast and prostate) on the cardiovascular system: effects and modifications: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2021;14(3):e000082.Huang R, Zhou Y, Hu S, et al. Radiotherapy exposure in cancer patients and subsequent risk of stroke: a systematic review and meta-analysis. Front Neurol. 2019;10:233.Tichelli A, Bucher C, Rovo A, et al. Premature cardiovascular disease after allogeneic hematopoietic stemcell transplantation. Blood. 2007;110(9):3463-71.Mitchell JD, Cehic DA, Morgia M, et al. Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the International Cardio-Oncology Society. JACC Cardio Oncol. 2021;3:360-80Nardin S, Mora E, Varughese FM, et al. Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Front Oncol. 2020;10:864.Van Nimwegen FA, Schaapveld M, Janus CPM, et al. Cardiovascular disease after Hodgkin lymphoma treatment 40-year disease risk. JAMA Intern Med. 2015;175:1007-17.Wei X, Liu HH, Tucker SL, et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2008;70:707-14.Banfill K, Giuliani M, Aznar M, et al. Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions. J Thorac Oncol. 2021;16:216-27.Popit M, Zaletel M, Žvan B, Zaletel LZ. Long-Term Adverse Effects of Neck Radiotherapy in Childhood on the Carotid Arteries in Survivors of Hodgkin Lymphoma. Cancers (Basel). 2023;15(15):3992.Bergom C, Bradley JA, Ng AK, et al. Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification. JACC Cardio Oncol. 2021;3:343-59.Liu LK, Ouyang W, Zhao X, et al. Pathogenesis and prevention of radiation-induced myocardial fibrosis. Asian Pac J Cancer Prev. 2017;18:583-7.Armstrong GT, Joshi VM, Ness KK, et al. Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: results from the St. Jude Lifetime Cohort Study. J Am Coll Cardiol. 2015;65:2511-22.Constine L, Schwartz R, Savage D, et al. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1997;39:897-906.Saiki H, Petersen IA, Scott CG, et al. Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer. Circulation. 2017;135:1388-96.Plana JC, Thavendiranathan P, Bucciarelli-Ducci C. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient. J Am Coll Cardiol Img. 2018;11:1173-86.Polomski EAS, Heemelaar JC, Krol ADG, et al Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors. Cancers (Basel). 2022;14(9):2329.Pudil R, Mueller C, Cˇelutkiene˙ J, et al. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Eur J Heart Fail. 2020;22:1966-83.Vallabhaneni S, Wang Y, Zhang Y, et al. Cardiovascular Magnetic Resonance in Early Detection of Radiation Associated Cardiotoxicity With Chest Radiation. Front Cardiovasc Med. 2022;9:1-7.Machann W, Beer M, Breunig M, et al. Cardiac magnetic resonance imaging fndings in 20-year survivors of mediastinal radiotherapy for Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 2011;79(4):1117-23.Traber J, Krempien R, Schulz-Menger J, von Knobelsdorf-Brenkenhof F. Assessment of acute radiation therapy-related cardiotoxicity by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2016;18(S1):1-2.Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229-361.Sárközy M, Varga Z, Gáspár R. Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside. Clinical Research in Cardiology. Clin Res Cardiol. 2021;110(4):507-31.DePasquale EC, Nasir K, Jacoby DL. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. J Heart Lung Transplant. 2012;31(12):1269-75.Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685-95.Desai MY, Windecker S, Lancellotti P, et al. Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;74:905-27.Stewart FA, Seemann I, Hoving S, Russell NS. Understanding radiation-induced cardiovascular damage and strategies for intervention. Clin Oncol (R Coll Radiol). 2013;25:617-24.Oeffinger KC, Mertens AC, Sklar CA, et al. Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572-82.Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 2005;44:13-22.Thakker R, Suthar K, Bhakta P, et al. Percutaneous Coronary Intervention Outcomes in Patients With Prior Thoracic Radiation Therapy: A Systematic Review and Meta-Analysis. Cardiol Res. 2022;13(6):333-8.Bijl JM, Roos MM, van Leeuwen-Segarceanu EM, et al. Assessment of valvular disorders in survivors of Hodgkin’s lymphoma treated by mediastinal radiotherapy +/- chemotherapy. Am J Cardiol. 2016;117(4):691-6.Wethal T, Lund MB, Edvardsen T, et al. Valvular dysfunction and left ventricular changes in Hodgkin’s lymphoma survivors. A longitudinal study. Br J Cancer. 2009;101:575-81.Donnellan E, Griffin BP, Johnston DR, et al. Rate of progression of aortic stenosis and its impact on outcomes in patients with radiation-associated cardiac disease: a matched cohort study. J Am Coll Cardiol Img. 2018;11:1072-80.Donnellan E, Masri A, Johnston DR, et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc. 2017;6(5):e005396.Zafar MR, Mustafa SF, Miller TW, et al. Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: a systematic review and meta-analysis. Cardiooncology. 2020;14(6):8.De Bruin ML, Dorresteijn LD, van’t Veer MB, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101:928-37.van Dijk IW, van der Pal HJ, van Os RM, et al. Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis. Int J Radiat Oncol Biol Phys. 2016;96(3):597-605.Jurado JA, Bashir R, Burket MW. Radiation-induced peripheral artery disease. Catheter Cardiovasc Interv. 2008;72:563-8.Murphy ES, Xie H, Merchant TE, et al. Review of cranial radiotherapy-induced vasculopathy. J Neurooncol. 2015;122(3):421-9.Ness KK, Armstrong GT. Screening for cardiac autonomic dysfunction among Hodgkin lymphoma survivors treated with thoracic radiation. J Am Coll Cardiol. 2015;65:584-5.Andratschke N, Maurer J, Molls M, Trott KR. Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother Oncol. 2011;100:160-6.Szabó G, Schmack B, Bulut C, et al. Constrictive pericarditis: risks, aetiologies and outcomes after total pericardiectomy: 24 years of experience. Eur J Cardiothorac Surg. 2013;44:1023-8.Lai YH, Chen HHW, Tsai YS. Accelerated coronary calcium burden in breast cancer patients after radiotherapy: a comparison with age and race matched healthy women. Radiat Oncol. 2021;16:210.Koppelmans V, Vernooij MW, BoogerdW, et al. Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy. J Clin Oncol. 2015;33:588-93.Leerink JM, van der Pal HJH, Kremer LCM, et al. Refining the 10-year prediction of left ventricular systolic dysfunction in longterm survivors of childhood cancer. JACC CardioOncology. 2021;3:62-72.Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5 – a populationbased study. Lancet Oncol. 2014;15:35-47.Armenian SH, Armstrong GT, Aune G, et al. Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention. J Clin Oncol. 2018;36:2135-44.Kremer LCM, van Dalen EC, Offringa M, Voûte PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol. 2002;13:503-5.Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31:3673-80.van Dalen EC, Mulder RL, Suh E, et al. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Eur J Cancer. 2021;156:127-37.Armenian SH, Hudson MM, Mulder RL, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer:a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16:e123-36.